IMR Press / FBS / Volume 1 / Issue 1 / DOI: 10.2741/S3

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Tendon tissue engineering with mesenchymal stem cells and biografts: an option for large tendon defects?
Show Less
1 Center for stem cells and Tissue Engineering, Tissue Engineering Center, School of Medicine, Zhejiang University, Hangzhou, P.R. China
2 Department of Orthopedic Surgery, Sir RawRaw Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China
3 Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China
4 Institute of Cell Biology, School of Medicine, Zhejiang University, Hangzhou, P.R. China

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Schol Ed) 2009, 1(1), 23–32; https://doi.org/10.2741/S3
Published: 1 June 2009
Abstract

The most important factors in the tissue engineering approach to tissue repair and regeneration are the use of appropriate cells and scaffolds. Mesenchymal stem cells (MSCs) are one of the most promising seed cells, which can be easily derived and have the potential to differentiate into various mesenchymal cell types as well as tenocytes in vitro and in vivo. Biological tendon grafts are the most common choice in current clinical practice, as they possess physical structure, strength and biocompatibility. We review the latest research findings on MSC-based tendon tissue engineering and recent advances in biological graft research.

Share
Back to top